Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gold

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2006
Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1Michael Joner, Andrew Farb, Qi Cheng, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 9, 2025
2024 Clinical Update in Liver TransplantationTrevor J Wilke, Emily A Vail, Andrew K Gold, et al.
Journal of the American College of Cardiology|April 1, 1993
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisH K Gold, F W Torres, H D Garabedian, et al.
The New England Journal of Medicine|July 26, 1984
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trialR Roberts, C Croft, H K Gold, et al.
Circulation|April 1, 1994
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trialE J Topol, V Fuster, R A Harrington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2008
Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheromaMichael Joner, Katsumi Morimoto, Hiroaki Kasukawa, et al.
Circulation|October 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activatorH K Gold, J T Fallon, T Yasuda, et al.
Circulation|December 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trialD Collen, E J Topol, A J Tiefenbrunn, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 13, 2018
Parents' and healthcare professionals' experiences of care after stillbirth in low- and middle-income countries: a systematic review and meta-summaryC Shakespeare, A Merriel, D Bakhbakhi, et al.
Journal of the American College of Cardiology|June 12, 2003
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantationCraig A Thompson, Boris A Nasseri, Joshua Makower, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2006
Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1Michael Joner, Andrew Farb, Qi Cheng, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 9, 2025
2024 Clinical Update in Liver TransplantationTrevor J Wilke, Emily A Vail, Andrew K Gold, et al.
Journal of the American College of Cardiology|April 1, 1993
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisH K Gold, F W Torres, H D Garabedian, et al.
The New England Journal of Medicine|July 26, 1984
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trialR Roberts, C Croft, H K Gold, et al.
Circulation|April 1, 1994
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trialE J Topol, V Fuster, R A Harrington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2008
Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheromaMichael Joner, Katsumi Morimoto, Hiroaki Kasukawa, et al.
Circulation|October 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activatorH K Gold, J T Fallon, T Yasuda, et al.
Circulation|December 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trialD Collen, E J Topol, A J Tiefenbrunn, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 13, 2018
Parents' and healthcare professionals' experiences of care after stillbirth in low- and middle-income countries: a systematic review and meta-summaryC Shakespeare, A Merriel, D Bakhbakhi, et al.
Journal of the American College of Cardiology|June 12, 2003
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantationCraig A Thompson, Boris A Nasseri, Joshua Makower, et al.
Pageof 27